2026年10月24日 10:30 ET 发布 · 更新于 21 天前 · 2 个来源
Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
CNBC Markets
·
原始报道
A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.
原文